CPDDs
| 【Numbering】BKME110002 | 【CAS】CAS | ||
| 【Item No.】BKME110002-2 | 【specification】 | ||
|
|||
Name: CPDDs
Composition: digoxin (DIG) + doxorubicin (DOX) + PLGA nanoparticles
Grain size: 50-200nm
Application: anti-tumor and tumor metastasis
Storage conditions: -4℃
Article link:https://doi.org/10.1016/j.apsb.2021.04.009
Message
Composition: digoxin (DIG) + doxorubicin (DOX) + PLGA nanoparticles
Grain size: 50-200nm
Application: anti-tumor and tumor metastasis
Storage conditions: -4℃
Other instructions: Half shelf life under sealed state [Main advantages] CPDD can accurately target homologous primary tumor cells and CTC clusters in blood and lymphatic circulation, and induce intracellular Ca 2 + accumulation by inhibiting Na + / K + -ATP enzyme, which helps to inhibit cell-cell junctions to break down CTC clusters. CPTT inhibits the epithelial-stromal transition process, thereby inhibiting escaping tumor cells from the primary site.
Article link:https://doi.org/10.1016/j.apsb.2021.04.009
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance |
Message
|
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance.The website pictures are from the Internet. The pictures are for reference only. Please take the real object as the standard. In case of infringement, please contact us to delete them immediately. |
Previous： the end...
Next： DIRAs
